didodecyldimethylammonium has been researched along with Kahler Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jääskeläinen, I; Lappalainen, K; Ollikainen, H; Pulkki, K; Syrjänen, S | 1 |
1 other study(ies) available for didodecyldimethylammonium and Kahler Disease
Article | Year |
---|---|
Liposomal targeting of bcl-2 antisense oligonucleotides with enhanced stability into human myeloma cell lines.
Topics: Cations; Cell Differentiation; Cell Division; Drug Carriers; Drug Stability; Gene Expression Regulation, Neoplastic; Gene Targeting; Genes, bcl-2; Humans; Liposomes; Multiple Myeloma; Oligonucleotides, Antisense; Phosphatidylethanolamines; Quaternary Ammonium Compounds; Tumor Cells, Cultured | 1996 |